Home Stocks AHCO Adapthealth Corp (NASDAQ: AHCO) Healthcare · Medical Devices
$7.37 −0.16 (−2.12%)
Last close · Nov 18, 2026 · NASDAQ USD
The Quantellect read. AHCO fell 2.12% in the Nov 18 session to $7.37. The borrow fee is 0.27%. Seven active firms cover the stock as of Nov 19, 2026; seven active firms with targets average $11.00 over 12 months. Descriptive summary of the data on this page, not a recommendation.
Relative valuation Lower multiples than peers P/S 0.3× vs peer median 2.7×
Momentum Overbought RSI (14) 76.4 (overbought above 70, oversold below 30)
Short interest 12.7% of float FINRA settlement Oct 30, 2026
SMA 10 — SMA 20 — SMA 50 — SMA 200 —
Price details unavailable for this range. ×
Chart loads when this section enters view.
Dated chart events require JavaScript on this compact chart. Open the full chart for dated events .
Text price and event history 6M plotted price range (ET) Range 6M First date — Last date — Open — High — Low — Close — Volume — Plotted bars 0
Plotted OHLCV bars No price bars are available for this range.
Event records Event records load after the price chart.
Split-adjusted daily prices · Price as of —
Initial 6M price range summary Range 6M First close — Last close — High — Low — Volume —
Open $7.41 Nov 18, 2026 session
Previous close $7.53 Nov 17, 2026 close
Day range $7.28 – $7.53 Nov 18, 2026 session
52-week range —
Volume 1.54M Nov 18, 2026 session
Average volume (30 calendar days) —
Market cap —
P/E (TTM) —
Forward P/E —
EPS (TTM) —
Dividend yield data unavailable —
Beta (5-year monthly vs SPY) —
Price history AHCO · NASDAQ · USD
Split-adjusted · volume in shares
Price history unavailable Retry
Notable price movement — · Notable price movement not available
Options flow — · Options flow not available
Q Score — · Q Score not available
How AHCO compares with its industry Against 139 other US-listed Medical Devices stocks
Dot = rank among peers, low to high · tick = peer median · colour marks the top and bottom 10%
Strongest pointsOne-month return was 28.1%, higher than 93% of 135 peers.Peer median −8.2% · As of Nov 16, 2026 Five-year annualized sales growth was 25.2%, higher than 76% of 85 peers.Peer median 15.9% · As of Nov 17, 2026 Points of cautionTrailing-year gross margin was 18.2%, with only 9% of 126 peers reporting a lower value.Peer median 59.0% · As of Nov 17, 2026 Current ratio was 1.13, with only 12% of 130 peers reporting a lower value.Peer median 2.97 · As of Nov 17, 2026 Valuation Lower multiples than peers
Metric AHCO Peer median
Profitability Profitability metrics are mixed versus peers.
Metric AHCO Peer median
Growth Growth metrics are higher than most peers.
Metric AHCO Peer median
Balance sheet Balance sheet metrics are lower than most peers.
Metric AHCO Peer median
Momentum Returns are mixed versus peers.
Metric AHCO Peer median
1-year return −18.1% −17.6%
Higher than 50% of 123 peers
6-month return −27.2% −5.8%
Higher than 35% of 127 peers
3-month return +33.0% −17.0%
Top 10% of peers Higher than 92% of 133 peers
How to read this The dot marks where AHCO ranks among its peers on each metric, from lowest (left) to highest (right). The tick in the middle marks the peer median.
Green marks a rank in the top 10% of peers, amber the bottom 10%. Valuation and balance-sheet metrics stay neutral because a high rank there is not better or worse.
A metric is ranked only when enough peers report it. Peers exclude this company. Percentages count peers with a strictly lower value; equal values do not count.
Lowest Median Highest
Compared with 139 other US-listed Medical Devices stocks · fundamentals as of Nov 18, 2026 · prices as of Nov 13, 2026
Upcoming events — · Upcoming events not available
Analyst consensus Buy
0 Strong Buy
7 Buy
0 Neutral
0 Sell
0 Strong Sell
Based on 7 active firms as of Nov 19, 2026 (365-day activity window)
12-month price targets (third-party analysts) Low $8.00
Average $11.00
High $16.00
As of Nov 19, 2026 across 7 active firms with targets. Targets are published by third-party analysts, not by Quantellect.
Full analyst forecast →
Earnings history EPS, last 8 quarters −1.50 −1.00 −0.50 0.00 0.50 1.00 FY ’24 Q1 ’25 Q2 ’25 Q3 ’25 FY ’25 Q1 ’26 Q2 ’26 Q3 ’26
Estimate Beat Miss Match
Fiscal period Est. Actual Result
Q3 2026 −$0.06 −$1.13 —
Q2 2026 — −$0.99 —
Q1 2026 $0.01 −$0.12 —
Annual 2025 — −$0.52 —
Q3 2025 — $0.16 —
Q2 2025 — $0.10 —
Q1 2025 — −$0.05 —
Annual 2024 $0.28 $0.61 —
Smart-money activity In the last 60 days: 0 insider sales and 0 purchases. Last quarter: 0 new 13F positions. No congressional trades in 90 days.
Date Type Who Action Amount Source
Aug 6, 2026 Insider buy WOLF DALE B Buy $126K Form 4 Aug 6, 2026 Insider buy SAMET KENNETH A Buy $149.9K Form 4 Aug 7, 2026 Insider buy WOLF DALE B Buy $117.2K Form 4 Aug 6, 2026 Insider buy WOLF DALE B Buy $127.4K Form 4 Jul 1, 2026 Insider sell Schuster III Russell E. Sell $117.7K Form 4 Jun 1, 2026 Insider sell Schuster III Russell E. Sell $113.4K Form 4 All smart-money activity →
News and press releases Year All 2026 2025 Nov 4, 2026, 4:05 PM ET Nov 3, 2026, 7:00 AM ET Oct 21, 2026, 8:00 AM ET All AHCO news → Company profile AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation
CEO Ms. Suzanne M. Foster M.P.H.
Headquarters Conshohocken, PA, United States
Employees 10,900
IPO date May 24, 2018
Sector Healthcare
Industry Medical Devices Q Score — · Q Score not available
Upcoming events — · Upcoming events not available
Analyst consensus Buy
0 Strong Buy
7 Buy
0 Neutral
0 Sell
0 Strong Sell
Based on 7 active firms as of Nov 19, 2026 (365-day activity window)
12-month price targets (third-party analysts) Low $8.00
Average $11.00
High $16.00
As of Nov 19, 2026 across 7 active firms with targets. Targets are published by third-party analysts, not by Quantellect.
Full analyst forecast →
Earnings history EPS, last 8 quarters −1.50 −1.00 −0.50 0.00 0.50 1.00 FY ’24 Q1 ’25 Q2 ’25 Q3 ’25 FY ’25 Q1 ’26 Q2 ’26 Q3 ’26
Estimate Beat Miss Match
Fiscal period Est. Actual Result
Q3 2026 −$0.06 −$1.13 —
Q2 2026 — −$0.99 —
Q1 2026 $0.01 −$0.12 —
Annual 2025 — −$0.52 —
Q3 2025 — $0.16 —
Q2 2025 — $0.10 —
Q1 2025 — −$0.05 —
Annual 2024 $0.28 $0.61 —
Company profile AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation
CEO Ms. Suzanne M. Foster M.P.H.
Headquarters Conshohocken, PA, United States
Employees 10,900
IPO date May 24, 2018
Sector Healthcare
Industry Medical Devices